Bioinformatics Shared Resource (BISR) The Bioinformatics Shared Resource (BISR) provides cutting-edge bioinformatics support and collaboration to advance cancer research at Norris Cotton Cancer Center (NCCC). Eight fulltime staff provide a variety of expertise and services, including applied bioinformatics and data mining, computer programming and software engineering, database development and administration, and high-performance computing and systems administration. Given the explosion of high-throughput data coming from genomics, proteomics and others areas, such as imaging, each of these services are essential to NCCC researchers. The BISR maintains a cutting-edge high-performance computing system called Discovery, that provides 2,000 processors to NCCC and Dartmouth community researchers. The resource has been utilized heavily for computationally intensive research by NCCC investigators. For example, Dr. Weaver, from Cancer Imaging & Radiobiology (CIR) has used it for simulating the Brownian motion of nanoparticles. The BISR is directed by Dr. Jason H. Moore, who serves as the Third Century Professor of Genetics and Director of the Institute for Quantitative Biomedical Sciences at Dartmouth College. Key staff members include Dr. Walter Taylor, who serves as the Managing Director of the BISR. He assists Dr. Moore with the day-to-day operation of the BISR, including meeting with faculty to assess bioinformatics support needs. Mr. Peter Schmitt, from the BISR, serves as the Technical Director of the Discovery cluster. The BISR has provided computational assistance and bioinformatics support for 37 members across all six of the NCCC Research Programs over the past year. These support activities range in scope from setting up workstations for the Cancer Control (CC) Program to developing novel machine-learning algorithms and software to support Cancer Epidemiology (CE). The BISR now provides a comprehensive set of services with appropriate support and computing infrastructure. As sources of funding have been identified, the staff of the BISR has grown to meet the demands created by emerging technologies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023108-39S5
Application #
9758105
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Belin, Precilla L
Project Start
Project End
2019-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
39
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
Durand, Marie-Anne; Yen, Renata West; O'Malley, A James et al. (2018) What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health 18:241
Soneji, Samir S; Sung, Hai-Yen; Primack, Brian A et al. (2018) Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 13:e0193328
Tosteson, Anna N A; Yang, Qian; Nelson, Heidi D et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat 167:195-203
Molodtsov, Aleksey; Turk, Mary Jo (2018) Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol 9:2810
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Brain Reward Responses Are Behaviorally Relevant: The Authors Respond. J Stud Alcohol Drugs 79:41-42
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824
Kumar, Nishant; Tafe, Laura J; Higgins, John H et al. (2018) Identifying Associations between Somatic Mutations and Clinicopathologic Findings in Lung Cancer Pathology Reports. Methods Inf Med 57:63-73

Showing the most recent 10 out of 1911 publications